B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma have?
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma has 795 citations in the OpenAlex counts ScholarIQ stores.
When was B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma published?
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma has 2019 year in the ScholarIQ index.
What is the open-access status of B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma?
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma has bronze oa status in the ScholarIQ index.
What is the DOI of B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma?
The DOI for B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma is on the source record.
What is the PMID of B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma?
The PMID for B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma is on the source record.
What is the OpenAlex record for B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma?
The OpenAlex for B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma is on the source record.